Quarterly report pursuant to sections 13 or 15(d)

Condensed Balance Sheets

v2.3.0.15
Condensed Balance Sheets (USD $)
Sep. 30, 2011
Dec. 31, 2010
ASSETS    
Cash $ 565,937 $ 167,374
Investments held in trust at amortized cost 50,253,008 0
Prepaid expenses 90,000 1,098
Deferred offering costs 0 110,392
Total assets 50,908,945 278,864
LIABILITIES AND SHAREHOLDERS' EQUITY    
Accrued expenses 20,000 64,906
Deferred underwriter's fee 2,250,000 0
Shareholder loan 0 192,261
Due to shareholders 206 206
Total liabilities 2,270,206 257,373
Maximum ordinary shares, subject to possible redemption 4,342,163 and 0 shares stated at conversion value, respectively 43,638,738 0
Shareholders' equity:    
Ordinary shares, $.001 par value Authorized 60,000,000 shares; 6,437,500 and 1,955,000 shares issued and outstanding respectively 1,906 1,955
Additional paid-in capital 5,308,396 42,945
Deficit accumulated during the development stage (310,301) (23,409)
Total shareholders' equity 5,000,001 21,491
Total liabilities and shareholders' equity $ 50,908,945 $ 278,864